Is history of malignancy a predictor of prostate cancer detection : incorporation into a pre-biopsy nomogram?
We demonstrated for the first time that history of malignancy is a potent predictor of prostate cancer in men with moderately elevated PSA even if the established risk factors are adjusted. The nomogram can be a useful tool in decision-making of prostate biopsy. In daily practice, history of malignancy should be rigorously taken from these men before a decision is made regarding prostate biopsy.
Higher taxes may be particularly effective in reducing smoking among University students in Jordan.